Literature DB >> 33410299

Does the CCR5-Δ32 mutation explain the variable coronavirus-2019 pandemic statistics in Europe?

Nad Starčević Čizmarević1, Marin Tota, Smiljana Ristić.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33410299      PMCID： PMC7821361     

Source DB:  PubMed          Journal:  Croat Med J        ISSN： 0353-9504            Impact factor:   1.351


× No keyword cloud information.
  8 in total

1.  COVID-19 infections are also affected by human ACE1 D/I polymorphism.

Authors:  Joris R Delanghe; Marijn M Speeckaert; Marc L De Buyzere
Journal:  Clin Chem Lab Med       Date:  2020-06-25       Impact factor: 3.694

2.  No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.

Authors:  Mostafa Saadat
Journal:  Clin Chem Lab Med       Date:  2020-06-25       Impact factor: 3.694

3.  Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.

Authors:  T C Dawson; M A Beck; W A Kuziel; F Henderson; N Maeda
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Frequency of CCR5 gene 32-basepair deletion in Croatian normal population.

Authors:  Smiljana Ristić; Nada Starcević Cizmarević; Bojana Brajenović-Milić; Marija Crnić-Martinović; Miljenko Kapović
Journal:  Croat Med J       Date:  2005-08       Impact factor: 1.351

5.  CCR5 deficiency predisposes to fatal outcome in influenza virus infection.

Authors:  A Falcon; M T Cuevas; A Rodriguez-Frandsen; N Reyes; F Pozo; S Moreno; J Ledesma; J Martínez-Alarcón; A Nieto; I Casas
Journal:  J Gen Virol       Date:  2015-04-27       Impact factor: 3.891

6.  Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.

Authors:  Ute V Solloch; Kathrin Lang; Vinzenz Lange; Irina Böhme; Alexander H Schmidt; Jürgen Sauter
Journal:  Hum Immunol       Date:  2017-10-05       Impact factor: 2.850

7.  An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19.

Authors:  Mostafa Saadat
Journal:  Clin Chim Acta       Date:  2020-05-23       Impact factor: 3.786

8.  The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections.

Authors:  Joris R Delanghe; Marijn M Speeckaert; Marc L De Buyzere
Journal:  Clin Chim Acta       Date:  2020-03-24       Impact factor: 3.786
  8 in total
  4 in total

1.  Could the CCR5-Delta32 mutation be protective in SARS-CoV-2 infection?

Authors:  N Starcevic Cizmarevic; M Kapovic; D Roncevic; S Ristic
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

2.  Update on human genetic susceptibility to COVID-19: susceptibility to virus and response.

Authors:  Vito Luigi Colona; Vasilis Vasiliou; Jessica Watt; Giuseppe Novelli; Juergen K V Reichardt
Journal:  Hum Genomics       Date:  2021-08-25       Impact factor: 4.639

3.  Host polymorphisms and COVID-19 infection.

Authors:  Joris R Delanghe; Marijn M Speeckaert
Journal:  Adv Clin Chem       Date:  2021-08-23       Impact factor: 5.394

4.  Allelic Variations in the Human Genes TMPRSS2 and CCR5, and the Resistance to Viral Infection by SARS-CoV-2.

Authors:  Girolamo Aurelio Vitello; Concetta Federico; Francesca Bruno; Mirella Vinci; Antonino Musumeci; Alda Ragalmuto; Valentina Sturiale; Desiree Brancato; Francesco Calì; Salvatore Saccone
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.